Shan Man

Continuous low-dose therapy with vinblastine and VEGF receptor-2 antibody induces sustained tumor regression without overt toxicity

Peter Bohlen, Robert S. Kerbel, S. Baruchel, 2000 .

Antitumor effects in mice of low-dose (metronomic) cyclophosphamide administered continuously through the drinking water.

Peter Bohlen, Gabriele Bergers, Shane K Green, 2002, Cancer research.

Down-regulation of DNA mismatch repair proteins in human and murine tumor spheroids: implications for multicellular resistance to alkylating agents

John M L Ebos, Shane K Green, Guido Bocci, 2005, Molecular Cancer Therapeutics.

Antitumor effects of combining metronomic chemotherapy with the antivascular action of ultrasound stimulated microbubbles

Kullervo Hynynen, Raffi Karshafian, David E Goertz, 2013, International journal of cancer.

Targeted anti-vascular endothelial growth factor receptor-2 therapy leads to short-term and long-term impairment of vascular function and increase in tumor hypoxia.

Limor Chen, Allison S Brown, D. Hicklin, 2006, Cancer research.

Differential Post-Surgical Metastasis and Survival in SCID, NOD-SCID and NOD-SCID-IL-2Rγnull Mice with Parental and Subline Variants of Human Breast Cancer: Implications for Host Defense Mechanisms Regulating Metastasis

Robert S. Kerbel, R. Kerbel, Christina R. Lee, 2013, PloS one.

Differences in therapeutic indexes of combination metronomic chemotherapy and an anti-VEGFR-2 antibody in multidrug-resistant human breast cancer xenografts.

Barbara Mayer, Peter Bohlen, Shane K Green, 2002, Clinical cancer research : an official journal of the American Association for Cancer Research.